过去一年中添加的文章，按日期排序
Comparing efficacy of erlotinib and bevacizumab combination with erlotinib monotherapy in patients with advanced non-small cell lung cancer (NSCLC): A systematic …
P Sakharkar, S Kurup - Diseases, 2023 - mdpi.com
242 天前 - … the efficacy and safety of combining erlotinib and bevacizumab with erlotinib alone
in … trials (RCTs) comparing erlotinib plus bevacizumab with erlotinib in NSCLC patients. The …
in … trials (RCTs) comparing erlotinib plus bevacizumab with erlotinib in NSCLC patients. The …
Phase I–IV Drug Trials on Hepatocellular Carcinoma in an Asian Population: A Systematic Review of Ten Years Studies
A Raghav, GB Jeong - 2024 - preprints.org
11 天前 - … bevacizumab was used for HCC after initial sorafenib treatment. Eighteen studies
compared the efficacy … , tepotinib, tigatuzumab, linifanib, erlotinib, resminostat, brivanib, …
compared the efficacy … , tepotinib, tigatuzumab, linifanib, erlotinib, resminostat, brivanib, …
99TiP A randomized phase II study of lazertinib alone versus lazertinib plus bevacizumab for advanced non-small cell lung cancer with epidermal growth factor …
BC Ahn, B Shim, HW Lee, MH Hong, S Lee, Y Lee… - ESMO Open, 2024 - esmoopen.com
112 天前 - … can extend progression-free survival (PFS) compared to erlotinib monotherapy,
these … to assess the efficacy and safety of combining lazertinib with bevacizumab in NSCLC …
these … to assess the efficacy and safety of combining lazertinib with bevacizumab in NSCLC …
[HTML][HTML] Subtype of EGFR exon 19 deletion mutations
N Fujimoto - Translational Lung Cancer Research, 2024 - ncbi.nlm.nih.gov
172 天前 - … that the combination of erlotinib and an anti-VEGF antibody bevacizumab would be
… chemotherapy demonstrated prolonged PFS compared to osimertinib monotherapy as a first…
… chemotherapy demonstrated prolonged PFS compared to osimertinib monotherapy as a first…